Researchers have found a new way to make the body’s immune cells (T cells) fight lung cancer more effectively. They used a special “connector” protein that helps T cells...
• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the...
Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...
Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...
CD99 is highly expressed in T cell acute lymphoblastic leukemia (T-ALL), a type of cancer. One promising treatment involves a mouse monoclonal antibody against CD99 called mAb MT99/3, which...
A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The...
A follow-up study on 50 adults investigated the impact of PM2.5 exposure on ocular health. Samples were collected before and after the high PM2.5 season, utilizing data from the...
Scientists have developed a new type of immunotherapy that uses genetically modified natural killer (NK) cells to target and destroy cancer cells. NK cells are a type of immune...